MyChem
- Company typePrivate
- Founded2007
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What MyChem does
MyChem is a privately held, for-profit specialty manufacturer founded in 2007 and based in San Diego, California. Per its firmographic profile, the company is specialized in making ultra-pure nucleotides — the building blocks of DNA and RNA used across molecular biology, genomics research, diagnostic assay development, and increasingly in therapeutic applications such as mRNA-based medicines and gene therapy. The company operates with a very lean team of 1-10 employees, indicating a boutique, technically focused operation rather than a high-volume commodity chemicals producer.
The company's product category positions it as a supplier into the life sciences research tools and biopharma inputs value chain, where purity specifications are critical and buyers are typically research institutions, diagnostic developers, and pharmaceutical or biotech companies. MyChem's website is hosted at mychemlabs.com, consistent with a laboratory-inputs branding posture.
The available source data is materially incomplete. Multiple collection attempts returned a verification/waiting page on the company website with no substantive product catalog, pricing, customer list, certifications, leadership bios, funding history, or revenue disclosures. As a result, no business model details (direct vs. distributor sales, catalog vs. custom synthesis, pricing tiers), no end-market segmentation, and no operating metrics are verifiable from the provided inputs. Any investment thesis built on MyChem will require primary diligence — direct outreach, sample customer interviews, and review of internal financials — to confirm revenue scale, customer concentration, and competitive positioning within the ultra-pure nucleotides market.
MyChem firmographics
Firmographics- Name
- MyChem
- Website
- https://mychemlabs.com
- Company type
- Private
- Founded year
- 2007
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
MyChem industry classification
Industry- Product category
- Biochemical Reagents
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Electronic & High-Purity Specialty Chemicals (IMAEABAD)
Keywords
Where MyChem is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
MyChem business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure
MyChem product offering
Product offeringCore offering
MyChem manufactures and supplies ultra pure nucleotides for molecular biology, diagnostics, and biotechnology research applications. The company operates a small specialty chemical production operation based in San Diego, California, focused on producing high-purity nucleotide reagents for life sciences customers.
Product overview
MyChem offers chemical analysis and laboratory services. The company website displays a verification page with no accessible product content at the time of data collection.
Differentiator
Problem solved
Functional benefit
Products and services
- Ultra Pure Nucleotides
Companies that use MyChem
Customer profileIdeal customer profiles1 record
MyChem technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MyChem competitors and assessment
Company assessmentBroad incumbents
- Agilent Technologies: Agilent supplies nucleic-acid reagents, oligonucleotides, and genomics consumables alongside its instruments. It overlaps with MyChem in research and diagnostic-grade nucleotide/nucleic-acid chemistry.
- Thermo Fisher Scientific: Thermo Fisher supplies nucleotides, modified nucleotides, and nucleic-acid reagents across research, diagnostics, and therapeutics through its extensive catalog. It is a broad incumbent competing across all of MyChem's potential end-markets.
- Sigma-Aldrich / Merck Life Science: Sigma-Aldrich/Merck is the dominant broad-line supplier of nucleotides, nucleosides, and life-science reagents. It competes with MyChem across the entire nucleotide catalog and sets the price/quality benchmark for the market.
Direct peers
- TriLink BioTechnologies (Maravai LifeSciences): TriLink is a leading manufacturer of nucleotides, mRNA building blocks, and clean cap analogs. It directly overlaps with MyChem's ultra-pure nucleotide specialization but operates at much greater scale within nucleic-acid therapeutics supply chains.
- Hongene Biotech: Hongene is a specialty manufacturer of nucleosides, nucleotides, and phosphoramidites used in RNA/DNA therapeutics and diagnostics. It is a direct comparable to MyChem in the high-purity nucleotide space.
- Nitto Denko Avecia: Avecia is a CDMO specializing in oligonucleotide and nucleic-acid manufacturing, including production of nucleotide building blocks. It is a direct peer serving therapeutics and diagnostics customers in the same value chain as MyChem.
- Glen Research: Glen Research manufactures reagents for oligonucleotide synthesis, including high-purity nucleoside phosphoramidites and related building blocks. It is a direct peer in the ultra-pure nucleotide/nucleoside supply category.
- ChemGenes Corporation: ChemGenes is a specialty manufacturer of nucleosides, nucleotides, phosphoramidites, and oligonucleotides used in DNA/RNA synthesis. It serves essentially the same customer set as MyChem and competes directly on ultra-pure raw materials.
- Biosynth (formerly BioSynth / Glen Research portfolio): Biosynth supplies specialty chemicals and reagents including nucleosides, nucleotides, and synthesis reagents for genomics and diagnostics. It directly competes in the ultra-pure nucleotide category MyChem serves.
- Integrated DNA Technologies (IDT, Danaher): IDT manufactures custom oligonucleotides, nucleotides, and nucleic-acid reagents for research and diagnostics. It is a direct comparable in the high-purity nucleotide/oligonucleotide space and shares San Diego-area roots with MyChem.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat2 records
Key risks5 records
Key highlights4 records
Customer concentration
MyChem financial estimates
Financial estimateRevenue estimate
Valuation estimate
MyChem leadership team
Management profileNumber of profiles
MyChem funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MyChem M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MyChem
What does MyChem do?
MyChem manufactures and supplies ultra pure nucleotides for molecular biology, diagnostics, and biotechnology research applications. The company operates a small specialty chemical production operation based in San Diego, California, focused on producing high-purity nucleotide reagents for life sciences customers.
When was MyChem founded?
MyChem was founded in 2007. It employs 1 to 10 people.
Where is MyChem based?
MyChem is headquartered in San Diego, United States, in the North America region.
Who are MyChem's main competitors?
Broad incumbents on record are Agilent Technologies, Thermo Fisher Scientific and Sigma-Aldrich / Merck Life Science. Direct peers are TriLink BioTechnologies (Maravai LifeSciences), Hongene Biotech, Nitto Denko Avecia, Glen Research, ChemGenes Corporation, Biosynth (formerly BioSynth / Glen Research portfolio) and Integrated DNA Technologies (IDT, Danaher).
Does MyChem have an API?
No public API is recorded for MyChem.
What industry is MyChem in?
MyChem's product category is Biochemical Reagents. Its primary akta.pro industry code is IMAEABAD, Electronic & High-Purity Specialty Chemicals. Its NAICS code is 3254 and its SIC code is 2860.